Literature DB >> 1637554

The bone morphogenetic protein family and osteogenesis.

J M Wozney1.   

Abstract

The BMPs (bone morphogenetic proteins) are a group of related proteins originally identified by their presence in bone-inductive extracts of demineralized bone. By molecular cloning, at least six related members of this family have been identified and are called BMP-2 through BMP-7. These molecules are part of the TGF-beta superfamily, based on primary amino acid sequence homology, including the absolute conservation of seven cysteine residues between the TGF-betas and the BMPs. The BMPs can be divided into subgroups with BMP-2 and BMP-4 being 92% identical, and BMP-5, BMP-6, and BMP-7 being an average of about 90% identical. To examine the individual activities of these molecules, we are producing each BMP in a mammalian expression system. In this system, each BMP is synthesized as a precursor peptide, which is glycosylated, processed to the mature peptide, and secreted as a homodimer. These reagents have been used to demonstrate that single molecules, such as BMP-2, are capable of inducing the formation of new cartilage and bone when implanted ectopically in a rodent assay system. Whether each of the BMPs possesses the same inductive activities in an animal is the subject of ongoing research. Based on the chondrogenic and osteogenic abilities of the BMPs in the adult animal, the expression of the mRNAs for the BMPs has been examined in the development of the embryonic skeleton by in situ hybridization. These studies demonstrate that the BMP mRNAs are spatially and temporally expressed appropriately for the proteins involved in the induction and development of cartilage and bone in the embryonic limb bud.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637554     DOI: 10.1002/mrd.1080320212

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  103 in total

Review 1.  Soluble, insoluble and geometric signals sculpt the architecture of mineralized tissues.

Authors:  U Ripamonti
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

2.  [Applying an osteoinductive protein complex for regeneration of osseous defects].

Authors:  F R Kloss; K A Schlegel; E Felszeghy; S Falk; J Wiltfang
Journal:  Mund Kiefer Gesichtschir       Date:  2004-01-20

3.  Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics study.

Authors:  Nikitas Sykaras; Anthony M Iacopino; Robert G Triplett; Victoria A Marker
Journal:  Clin Oral Investig       Date:  2004-07-29       Impact factor: 3.573

4.  The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2.

Authors:  Hiroshi Ohta; Shigeyuki Wakitani; Keiji Tensho; Hiroshi Horiuchi; Shinji Wakabayashi; Naoto Saito; Yukio Nakamura; Kazutoshi Nozaki; Yuuki Imai; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

5.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

6.  Individual and combined effects of calciotropic hormones and growth factors on mineral metabolism in embryonic chick tibiae.

Authors:  C Duvos; A Scutt; H Mayer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

7.  Regulation of tenascin expression in bone.

Authors:  Jessica M Morgan; Alice Wong; Clare E Yellowley; Damian C Genetos
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

8.  Akt promotes BMP2-mediated osteoblast differentiation and bone development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

Review 9.  Evolving application of biomimetic nanostructured hydroxyapatite.

Authors:  Norberto Roveri; Michele Iafisco
Journal:  Nanotechnol Sci Appl       Date:  2010-11-09

10.  Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum.

Authors:  Orasa Anusaksathien; Qiming Jin; Ming Zhao; Martha J Somerman; William V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.